Profile
PTPI ZTS TAK HLN TEVA NBIX
Company Name Petros Pharmaceuticals, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $872.48K $67.90B $47.69B $43.90B $22.86B $14.30B
Employees 0.02K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Fady Boctor Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
PTPI ZTS TAK HLN TEVA NBIX
Quant Rating Score 2 3 3 3 1 4
Quant Rating Sell Neutral Neutral Neutral Strong Sell Buy
Trading
PTPI ZTS TAK HLN TEVA NBIX
Last Close $0.028 $146.25 $15.06 $9.68 $18.89 $140.44
High 52 $0.5 $196.48 $15.52 $11.41 $22.77 $153.29
Low 52 $0.01 $144.45 $12.89 $9.01 $12.82 $87.59
Price vs. 52 Week High -94.4 % -25.56 % -2.96 % -15.16 % -17.04 % -8.38 %
Price vs. 52 Week Low 180 % 1.25 % 16.83 % 7.44 % 47.35 % 60.34 %
Total Return
PTPI ZTS TAK HLN TEVA NBIX
1 Month Return -8.5 % -5.1 % 0.4 % 0.31 % 5.77 % 5.67 %
3 Month Return 3.7 % -11.03 % -0.07 % -9.7 % 7.94 % 12.35 %
6 Month Return -66.82 % -9.31 % 0.33 % -4.63 % 15.68 % 26.81 %
9 Month Return -89.51 % -16.81 % 13.4 % -0.41 % 14.42 % 5.55 %
YTD Return -92.89 % -10.24 % 13.75 % 1.47 % -14.29 % 2.89 %
1 Year Return -92.6 % -24.71 % 1.76 % -8.85 % 4.54 % 14.88 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PTPI ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.26 % 4.36 % 0.02 % - -
Dividend Paid and Capex Coverage Ration (TTM) -0 % 1.89 % 2.03 % - 2.78 % 14.7 %
Dividend Per Share (TTM) - 1.93 % 196 % 0.06 % - -
Payout Ratio (TTM) -13011.63 % 32.08 % 226.17 % - - -
Profitability
PTPI ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 76.03 % 70.03 % 60.54 % 61.52 % 49.6 % 98.49 %
Return on Assets TTM -112.5 % 18.04 % 0.98 % 4.2 % -0.39 % 8.95 %
Return on Equity TTM 350.82 % 53.21 % 1.95 % 8.74 % -2.58 % 13.22 %
Return on Capital Employed TTM -331.24 % 31.67 % 3.43 % 7.74 % 3.16 % 14.8 %
Net Income Per EBT TTM 56.47 % 78.72 % 72.1 % 75.5 % 222.54 % 66.08 %
EBT Per Ebit TTM 100.03 % 94.26 % 46.84 % 86.58 % -7.94 % 106.48 %
EBIT Per Revenue TTM -639.94 % 37.51 % 9.05 % 19.64 % 5.38 % 19.72 %
Cash Flow To Debt Ratio TTM - 43.13 % 23.79 % - 7.93 % 129.2 %
Receivables Turnover TTM - 6.09 6.59 5.9 4.67 4.21
Payables Turnover TTM 0.57 5.54 4.53 2.19 3.35 0.36
Inventory Turnover TTM - 1.15 1.54 3.63 2.4 0.66
Fixed Asset Turnover TTM - 244.46 % 229.02 % 584.75 % 321.73 % 429.78 %
Asset Turnover TTM 31.12 % 64.82 % 31.99 % 32.73 % 41.43 % 64.53 %
Operating Cash Flow Per Share TTM -0.17 6.58 684.97 - 1.21 5.73
Free Cash Flow Per Share TTM -0.17 4.99 531.34 - 0.78 5.34
Cash Per Share TTM 28.24 % 322.4 % 26788.97 % 24.05 % 188.4 % 985.45 %
Operating Cash Flow Sales Ratio TTM -187.14 % 31.21 % 23.92 % - 8.36 % 22.6 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.57 % 75.76 % 77.57 % - 64.03 % 93.2 %
Cash Flow Coverage Ratios TTM - 43.13 % 23.79 % - 7.93 % 129.2 %
Price To Free Cash Flows Ratio TTM -0.2 30.6 8.44 - 25.45 27.05
Price To Operating Cash Flows Ratio TTM -0.17 23.28 6.56 - 16.3 25.16
Price Cash Flow Ratio TTM -0.17 23.28 6.56 - 16.3 25.16
Income Statement (TTM)
PTPI ZTS TAK HLN TEVA NBIX
Revenue $0.01B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $0B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio 76.28% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $-0.01B $3.87B $1210.51B $2.51B $0.78B $0.64B
Net Income $-0.01B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted -3.34 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
PTPI ZTS TAK HLN TEVA NBIX
Long Term Debt $0B $5.39B $4517.23B $8.54B $16.3B $0.46B
Total Liabilities $0.02B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $-0.01B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $3.71B $0B $10.8B $0.08B $0B $1.71B
Total Debt $0.01B $6.74B $5066.17B $10.1B $18.08B $0.46B
Total Assets $0.01B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
PTPI ZTS TAK HLN TEVA NBIX
Net Income $-0.01B $2.5B $107.93B $1.44B $-1.96B $0.34B
Inventory $0B $-0.04B $-34.97B $0.22B $0.17B $-0.02B
Dividends Paid $-1.29B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $-0B $2.95B $1057.18B $2.3B $1.25B $0.6B
Capital Expenditure $-0B $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 5.01
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 3.395
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 7.96
ALVOW Alvotech 1.04
AMPH Amphastar Pharmaceuticals, Inc. 26.99
AMRX Amneal Pharmaceuticals, Inc. 9.745
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 97.57
APUS Apimeds Pharmaceuticals US, Inc 1.88
AQST Aquestive Therapeutics, Inc. 4.865
ASRT Assertio Holdings, Inc. 0.84
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 15.41
ETFs With Exposure to PTPI
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 209.17
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 158.85
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 158.86
VEMPX Vanguard Extended Market Index InstlPlus 0 392.02
Unlock